298 related articles for article (PubMed ID: 20636956)
1. The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus.
Mostafa SA; Davies MJ; Webb D; Gray LJ; Srinivasan BT; Jarvis J; Khunti K
Diabet Med; 2010 Jul; 27(7):762-9. PubMed ID: 20636956
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities].
Gołembiewska E
Ann Acad Med Stetin; 2004; 50(1):131-8. PubMed ID: 16871752
[TBL] [Abstract][Full Text] [Related]
3. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
[TBL] [Abstract][Full Text] [Related]
4. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
Borg R; Vistisen D; Witte DR; Borch-Johnsen K
Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
[TBL] [Abstract][Full Text] [Related]
5. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
[TBL] [Abstract][Full Text] [Related]
6. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review.
Bennett CM; Guo M; Dharmage SC
Diabet Med; 2007 Apr; 24(4):333-43. PubMed ID: 17367307
[TBL] [Abstract][Full Text] [Related]
7. Incidence of type 2 diabetes by HbA1c and OGTT: the Isfahan Diabetes Prevention Study.
Janghorbani M; Amini M
Acta Diabetol; 2012 Dec; 49 Suppl 1():S73-9. PubMed ID: 21340503
[TBL] [Abstract][Full Text] [Related]
8. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
9. Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population.
Costa B; Barrio F; Cabré JJ; Piñol JL; Cos FX; Solé C; Bolibar B; Castell C; Lindström J; Barengo N; Tuomilehto J;
Diabet Med; 2011 Oct; 28(10):1234-7. PubMed ID: 21429007
[TBL] [Abstract][Full Text] [Related]
10. Hba(1c) as a tool for the diagnosis of type 2 diabetes: comparison with fasting glucose.
Tatsch E; Bochi GV; Piva SJ; Pereira RS; Kober H; De Carvalho JA; Sangoi MB; Duarte MM; Moresco RN
Clin Lab; 2012; 58(3-4):347-50. PubMed ID: 22582512
[TBL] [Abstract][Full Text] [Related]
11. Undiagnosed diabetes in the over-60s: performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practice.
Hayes L; Hawthorne G; Unwin N
Diabet Med; 2012 Jan; 29(1):115-20. PubMed ID: 21781154
[TBL] [Abstract][Full Text] [Related]
12. Performance of HbA(1c) for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing.
Zhou XH; Ji LN; Luo YY; Zhang XY; Han XY; Qiao Q
Diabet Med; 2009 Dec; 26(12):1262-8. PubMed ID: 20002479
[TBL] [Abstract][Full Text] [Related]
13. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations.
Manley SE; Sikaris KA; Lu ZX; Nightingale PG; Stratton IM; Round RA; Baskar V; Gough SC; Smith JM
Diabet Med; 2009 Feb; 26(2):115-21. PubMed ID: 19236612
[TBL] [Abstract][Full Text] [Related]
14. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of stable HbA(1c) for supportive marker to diagnose diabetes mellitus in Japanese subjects.
Tanaka Y; Atsumi Y; Matsuoka K; Mokubo A; Asahina T; Hosokawa K; Shimada S; Matsunaga H; Takagi M; Ogawa O; Onuma T; Kawamori R
Diabetes Res Clin Pract; 2001 Jul; 53(1):41-5. PubMed ID: 11378212
[TBL] [Abstract][Full Text] [Related]
16. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo GM; Leonetti F; Del Prato S;
Diabetes Care; 2012 Dec; 35(12):2607-12. PubMed ID: 22912427
[TBL] [Abstract][Full Text] [Related]
18. HbA(1c) in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study.
Pajunen P; Peltonen M; Eriksson JG; Ilanne-Parikka P; Aunola S; Keinänen-Kiukaanniemi S; Uusitupa M; Tuomilehto J; Lindström J;
Diabet Med; 2011 Jan; 28(1):36-42. PubMed ID: 21166843
[TBL] [Abstract][Full Text] [Related]
19. Glycaemia-independent ethnic differences in HbA(1c) in subjects with impaired glucose tolerance.
Likhari T; Gama R
Diabet Med; 2009 Oct; 26(10):1068-9. PubMed ID: 19900241
[TBL] [Abstract][Full Text] [Related]
20. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals.
Santos-Rey K; Fernández-Riejos P; Mateo J; Sánchez-Margalet V; Goberna R
Clin Chem Lab Med; 2010 Dec; 48(12):1719-22. PubMed ID: 20846105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
